Predictive factors for successful conversion therapy in gastric cancer with peritoneal metastasis: a case-control study
Achieving R0 resection through conversion therapy can significantly improve the prognosis of GC patients with PM. For patients with no significant elevation of CA125, it is advisable to consider implementing an aggressive first-line regimen in conjunction with a PD-1 inhibitor for the purpose of conversion therapy.
Authors
- Zhongqiang Zheng (ORCID: https://orcid.org/0000-0002-3765-8768)
- Xuanzi Sun
Institutions
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Journal of Gastrointestinal Oncology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21037/jgo-2025-230
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00